SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-119264
Filing Date
2016-05-09
Accepted
2016-05-09 16:38:03
Documents
66
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6558_110q.htm 10-Q 1032483
2 EX-31.1 a16-6558_1ex31d1.htm EX-31.1 10398
3 EX-31.2 a16-6558_1ex31d2.htm EX-31.2 11201
4 EX-32.1 a16-6558_1ex32d1.htm EX-32.1 4269
5 EX-32.2 a16-6558_1ex32d2.htm EX-32.2 4274
  Complete submission text file 0001104659-16-119264.txt   5116219

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20160331.xml EX-101.INS 1242785
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20160331.xsd EX-101.SCH 38823
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20160331_cal.xml EX-101.CAL 42061
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20160331_def.xml EX-101.DEF 118518
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20160331_lab.xml EX-101.LAB 380414
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20160331_pre.xml EX-101.PRE 258687
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 161632198
SIC: 2834 Pharmaceutical Preparations